M33.91 identifies dermatopolymyositis of unspecified subtype that is documented with respiratory system involvement, such as interstitial lung disease or inflammatory myopathy-associated lung complications.

Documentation tips

What should appear in the chart to support M33.91.

Source · Editorial brief grounded in 5 cited references ↓

• Document the specific type of respiratory involvement (e.g., interstitial lung disease, aspiration pneumonia, respiratory muscle weakness) — this supports medical necessity for secondary codes like J84.10 and justifies MCC/CC capture.
• Specify the dermatomyositis subtype when known: juvenile onset routes to M33.01, other/adult dermatomyositis to M33.11, polymyositis to M33.21 — all three are more specific than M33.91 and should be used when the record supports them.
• Record whether myopathy is present or absent alongside respiratory involvement; if both are documented, both fifth-character manifestations may be reportable and the provider should clarify the primary diagnosis.
• Note any laboratory or imaging findings that confirm diagnosis — creatine kinase levels, aldolase, myositis-specific antibodies (anti-Jo-1), HRCT findings of ILD, or pulmonary function test results — to support the inflammatory myopathy diagnosis on audit.
• For EMG/nerve conduction encounters using CPT 95860–95913, the diagnosis code must appear in the CMS-covered ICD list (A54969); M33.91 qualifies, so ensure the encounter note ties the neuromuscular study to the dermatomyositis diagnosis explicitly.

Related CPT procedures

Procedure codes commonly billed with M33.91. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M33.91 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Defaulting to M33.91 when a more specific subtype is documented — if the chart says 'adult dermatomyositis' with respiratory involvement, the correct code is M33.11, not M33.91.
• Omitting the secondary respiratory manifestation code (e.g., J84.10 for ILD) and losing the MCC designation that shifts the DRG from 547 to 545, significantly affecting reimbursement.
• Coding M33.92 (with myopathy) when the note documents both myopathy and respiratory involvement without querying the provider about which is the primary manifestation — dual coding may be appropriate but requires physician clarification.
• Confusing M33.91 with M36.0 (Dermato(poly)myositis in neoplastic disease) when a patient has a concurrent malignancy; if the dermatomyositis is paraneoplastic, M36.0 is the correct code and the neoplasm is coded first.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M33.9 (laterality / anatomic variants).